PTC Therapeutics, Inc. (NASDAQ:PTCT) Director Jerome B. Zeldis Sells 20,000 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) Director Jerome B. Zeldis sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $38.24, for a total transaction of $764,800.00. Following the transaction, the director now owns 14,500 shares of the […]
More Stories
20+ SEO Checklist For Blog Posts: Read Before Publishing
You wrote a fantastic blog. What’s next? Publishing blogs without optimizing them for SEO is like starting a shop without...
US Military Blockade on Iranian Ports Goes Into Effect, Maritime Group Says
By Jack Phillips A scheduled U.S. naval blockade of the Strait of Hormuz and nearby waters started at 10 a.m....
Who is Jonathan Joly? Age, Marriage, and Net Worth in 2026
If you like to scroll on social media, the chances of you witnessing Jonathan Joly are high. Are you also...
Rory McIlroy Wins Back-to-Back Masters Titles to Join Jack Nicklaus, Nick Faldo, and Tiger Woods
By The Associated Press AUGUSTA, Ga.—Rory McIlroy joined more elite company Sunday at the Masters when he pulled away with...
At Least 30 Dead in Stampede at Haiti’s Historic Laferriere Citadel
By Reuters At least 30 people were killed on Saturday in a stampede in the northern countryside of Haiti, authorities...
Oil Prices Rise After US Announces Blockade on Iranian Ports
By Naveen Athrappully Brent crude oil futures prices surged late Sunday following the United States threatening to block Iranian ports...